A Protein Supplementation and Exercise Strategy to Promote Muscle Protein Anabolism in Frail Elderly People
ProMuscle
1 other identifier
interventional
62
1 country
1
Brief Summary
The present study is designed to investigate whether timed protein supplementation will increase skeletal muscle mass in the frail elderly population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 12, 2010
CompletedFirst Posted
Study publicly available on registry
April 26, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedApril 4, 2025
April 1, 2025
1.7 years
February 12, 2010
April 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in skeletal muscle mass
Baseline, 3 months and 6 months
Secondary Outcomes (6)
Physical performance
Baseline, 3 months and 6 months
Blood will be collected to assess parameters related to the outcome measures
Baseline, 3 months and 6 months
Dietary intake
Baseline, 3 months and 6 months
Physical activity
Baseline, 3 months and 6 months
Cognitive performance
Baseline and 6 months
- +1 more secondary outcomes
Study Arms (2)
Resistance exercise training and protein drink
EXPERIMENTALResistance exercise training and placebo drink
PLACEBO COMPARATORInterventions
Protein drink twice a day during 6 months.
Resistance exercise training twice per week during 6 months.
Placebo drink twice a day during 6 months.
Eligibility Criteria
You may qualify if:
- Frail elderly individuals
- Able to understand and perform the study procedures
You may not qualify if:
- Type I or type II diabetes (fasted blood glucose level ≥7,0 mmol)
- No recent history (within 2 years) of participating in any regular resistance exercise training program (general questionnaire)
- Use of anti-coagulation medication (except of Acetyl Salicyl acid)
- Presence of coronary heart disease (ECG)
- Renal insufficiency (eGFR \<60 mL/min/1.73 m2)
- Allergic or sensitive for milk proteins
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wageningen Universitylead
- Top Institute Food and Nutritioncollaborator
- Maastricht University Medical Centercollaborator
Study Sites (1)
Wageningen University
Wageningen, Gelderland, 6703HD, Netherlands
Related Publications (3)
Dorhout BG, de Groot LCPGM, van Dongen EJI, Doets EL, Haveman-Nies A. Effects and contextual factors of a diet and resistance exercise intervention vary across settings: an overview of three successive ProMuscle interventions. BMC Geriatr. 2022 Mar 9;22(1):189. doi: 10.1186/s12877-021-02733-6.
PMID: 35264105DERIVEDvan de Rest O, van der Zwaluw NL, Tieland M, Adam JJ, Hiddink GJ, van Loon LJ, de Groot LC. Effect of resistance-type exercise training with or without protein supplementation on cognitive functioning in frail and pre-frail elderly: secondary analysis of a randomized, double-blind, placebo-controlled trial. Mech Ageing Dev. 2014 Mar-Apr;136-137:85-93. doi: 10.1016/j.mad.2013.12.005. Epub 2013 Dec 27.
PMID: 24374288DERIVEDTieland M, Dirks ML, van der Zwaluw N, Verdijk LB, van de Rest O, de Groot LC, van Loon LJ. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc. 2012 Oct;13(8):713-9. doi: 10.1016/j.jamda.2012.05.020. Epub 2012 Jul 6.
PMID: 22770932DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisette de Groot, Professor
Wageningen University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 12, 2010
First Posted
April 26, 2010
Study Start
November 1, 2009
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
April 4, 2025
Record last verified: 2025-04